微型和增强的CRISPR激活器用于癌症治疗
Meiyu Huang1, Keshan Wang2, Anshu Li3
1College of Life Sciences, Guangxi Normal University, Guilin, China.
Journal of advanced research
|November 5, 2024
概括
研究人员开发了一种新的CRISPR激活 (CRISPRa) 工具,dCas9-NVPR,证明了增强的基因激活和特异性. 这种工具通过恢复瘤抑制基因表达,有效地抑制了癌细胞的增殖,显示了癌症基因治疗的前景.
科学领域:
- 分子生物学分子生物学
- 基因编辑 基因编辑
- 癌症研究 癌症研究
背景情况:
- CRISPR-Cas9是一种可编程的转录激活剂,在真核生物中具有潜力.
- 现有的CRISPR激活 (CRISPRa) 工具需要优化以提高有效性.
- 克里斯普拉在癌症遗传疗法中的应用仍未得到充分研究.
研究的目的:
- 通过选转录辅激剂来构建优化的CRISPRa工具.
- 评估新型CRISPRa系统在激活内源基因方面的有效性.
- 通过向瘤抑制基因,评估CRISPRa在癌症基因治疗中的潜力.
主要方法:
- 对转录协活性剂的选和与dCas9-VPR系统的融合.
- 使用流细胞计和qRT-PCR对基因表达的分析.
- 使用RNA-seq. 的全基因组特异性评估.
- 在基因激活后评估癌细胞增殖和克隆形成.
主要成果:
- 鉴定了来自C. elegans的NHR模块,具有高转录激活能力.
- 开发了增强的CRISPR工具dCas9-NVPR,其性能优于现有的VPR模块.
- 在全基因组范围内证明了dCas9-NVPR的高特异性.
- 成功恢复了瘤抑制基因PER2和ZNF382的表达,抑制了癌细胞恶性病变.
结论:
- 开发了一个突破性的CRISPRa工具,dCas9-NVPR,提高了效率和特异性.
- 通过向瘤抑制基因,验证了CRISPRa在癌症遗传治疗中的潜力.
- 扩大了基因编辑工具包,并加强了基于CRISPR的精准医学的前景.
相关概念视频
CRISPR
49.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Homologous Recombination
50.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K
CRISPR and crRNAs
16.8K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.8K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K


